Jyothy Laboratories announced a marginal rise in consolidated net profit for the quarter ended June 2015. During the quarter, the profit of the company rose 4.97% to Rs 445.80 million from Rs 424.70 million in the same quarter previous year.
Revenues for the quarter rose 7.49% to Rs 4,143.40 million, compared with Rs 3,855 million for the prior year period.
Operating margin for the quarter stood at 12.14 percent as compared to 11.38 percent for the previous year period. Operating Income for the quarter was Rs 503.10 million, compared with Rs 438.8 million in the previous year period.
Earnings per share for the quarter stood at Rs 2.43, registering 3.40% growth over previous year period.
The Operating EBITDA margin for the quarter stood at 16.6% as against 13.5% and EPS rose to Rs 2.46 as against Rs 2.35 for the same period last year.
M P Ramachandran, chairman & managing director, Jyothy Laboratories said, ''Jyothy has delivered reasonable growth. Softening of commodity prices helped us in improving our operating margins by 4%. During the quarter our market shares of all Brands have shown good improvement. With a slew of innovative product launches and other initiatives planned during the year, we are extremely optimistic about FY16 and are confident that company will not only improve its market share but will also grow ahead of market.''
| Quarterly Results - Consolidated (Rs in mn) |
| As at | Jun - 15 | Jun - 14 | %Change |
| Revenues | 4,143.40 | 3,854.80 | 7.49 |
| Net Profit | 445.80 | 424.70 | 4.97 |
| Diluted EPS | 2.43 | 2.35 | 3.40 |
Shares of the company declined Rs 5.55, or 1.79%, to trade at Rs 304.60. The total volume of shares traded was 35,233 at the BSE (1.11 p.m., Thursday).
